Annual Cash & Cash Equivalents
$39.55 M
-$258.63 M-86.74%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual cash & cash equivalents is $39.55 million, with the most recent change of -$258.63 million (-86.74%) on December 31, 2023.
- During the last 3 years, TBPH annual cash & cash equivalents has fallen by -$41.92 million (-51.46%).
- TBPH annual cash & cash equivalents is now -89.54% below its all-time high of $378.02 million, reached on December 31, 2018.
Performance
TBPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$23.38 M
-$22.97 M-49.56%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly cash and cash equivalents is $23.38 million, with the most recent change of -$22.97 million (-49.56%) on September 30, 2024.
- Over the past year, TBPH quarterly cash and cash equivalents has dropped by -$48.31 million (-67.39%).
- TBPH quarterly cash and cash equivalents is now -94.41% below its all-time high of $418.54 million, reached on September 30, 2022.
Performance
TBPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TBPH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -86.7% | -67.4% |
| 3 y3 years | -51.5% | -80.8% |
| 5 y5 years | -89.5% | -71.3% |
TBPH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.7% | at low | -94.4% | at low |
| 5 y | 5-year | -86.7% | at low | -94.4% | at low |
| alltime | all time | -89.5% | -100.0% | -94.4% | -100.0% |
Theravance Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.38 M(-49.6%) |
| Jun 2024 | - | $46.34 M(-13.9%) |
| Mar 2024 | - | $53.84 M(+36.1%) |
| Dec 2023 | $39.55 M(-86.7%) | $39.55 M(-44.8%) |
| Sep 2023 | - | $71.69 M(-32.1%) |
| Jun 2023 | - | $105.60 M(-43.7%) |
| Mar 2023 | - | $187.66 M(-37.1%) |
| Dec 2022 | $298.17 M(+231.5%) | $298.17 M(-28.8%) |
| Sep 2022 | - | $418.54 M(+379.5%) |
| Jun 2022 | - | $87.29 M(-7.5%) |
| Mar 2022 | - | $94.37 M(+4.9%) |
| Dec 2021 | $89.96 M(+10.4%) | $89.96 M(-25.9%) |
| Sep 2021 | - | $121.42 M(-40.8%) |
| Jun 2021 | - | $204.95 M(+79.8%) |
| Mar 2021 | - | $114.01 M(+39.9%) |
| Dec 2020 | $81.47 M(+40.3%) | $81.47 M(-12.7%) |
| Sep 2020 | - | $93.28 M(-10.9%) |
| Jun 2020 | - | $104.73 M(-68.5%) |
| Mar 2020 | - | $332.80 M(+473.2%) |
| Dec 2019 | $58.06 M | $58.06 M(-43.3%) |
| Sep 2019 | - | $102.40 M(-42.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $178.31 M(-20.1%) |
| Mar 2019 | - | $223.24 M(-40.9%) |
| Dec 2018 | $378.02 M(+324.8%) | $378.02 M(+273.5%) |
| Sep 2018 | - | $101.20 M(-2.6%) |
| Jun 2018 | - | $103.85 M(-17.5%) |
| Mar 2018 | - | $125.83 M(+41.4%) |
| Dec 2017 | $88.98 M(-74.2%) | $88.98 M(-2.5%) |
| Sep 2017 | - | $91.30 M(-34.6%) |
| Jun 2017 | - | $139.63 M(-17.8%) |
| Mar 2017 | - | $169.94 M(-50.7%) |
| Dec 2016 | $344.71 M(+205.8%) | $344.71 M(+298.2%) |
| Sep 2016 | - | $86.57 M(-41.6%) |
| Jun 2016 | - | $148.36 M(+15.2%) |
| Mar 2016 | - | $128.80 M(+14.3%) |
| Dec 2015 | $112.71 M(+26.3%) | $112.71 M(-11.3%) |
| Sep 2015 | - | $127.11 M(+30.9%) |
| Jun 2015 | - | $97.09 M(-3.8%) |
| Mar 2015 | - | $100.90 M(+13.1%) |
| Dec 2014 | $89.22 M(>+9900.0%) | $89.22 M(-27.0%) |
| Sep 2014 | - | $122.23 M(-54.4%) |
| Jun 2014 | - | $268.20 M(>+9900.0%) |
| Dec 2013 | $0.00 | $0.00 |
FAQ
- What is Theravance Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Theravance Biopharma?
- What is Theravance Biopharma annual cash & cash equivalents year-on-year change?
- What is Theravance Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Theravance Biopharma?
- What is Theravance Biopharma quarterly cash and cash equivalents year-on-year change?
What is Theravance Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of TBPH is $39.55 M
What is the all time high annual cash & cash equivalents for Theravance Biopharma?
Theravance Biopharma all-time high annual cash & cash equivalents is $378.02 M
What is Theravance Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, TBPH annual cash & cash equivalents has changed by -$258.63 M (-86.74%)
What is Theravance Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TBPH is $23.38 M
What is the all time high quarterly cash and cash equivalents for Theravance Biopharma?
Theravance Biopharma all-time high quarterly cash and cash equivalents is $418.54 M
What is Theravance Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, TBPH quarterly cash and cash equivalents has changed by -$48.31 M (-67.39%)